DevelopingDay 2

FDA's GLP-1 NAION warning order

Update 1 of 1LatestNov 10, 7:31 AM UTCDay 2
FDA orders GLP-1 eye-risk warnings: what the numbers mean
The class-wide warning concerns rare, potentially permanent vision loss. The evidence warrants attention—not blanket advice to abandon treatment.
Watch
Earliest sourceU.S. Food and Drug AdministrationNov 9, 12:00 AM UTC
What we knew first
- 6.4Probable events per 100,000 person-years: GLP-1 treatment
- 3.8Probable events per 100,000 person-years: comparison treatment
- 15Probable events across both trial groups

Who reported

Who reported

17 outlets · 24 sources

12 of 17 had reported by this moment

U.S. Food and Drug AdministrationFirst to reportfda.gov · Nov 9, 12:00 AM UTC1
1. FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition | FDANov 9 UTC
reuters.comreuters.com · Nov 9, 3:59 PM UTC1
1. US FDA orders new eye risk warnings for Ozempic, Zepbound - ReutersNov 9 UTC
Amino Wireaminowire.news · Nov 9, 4:13 PM UTC1
1. FDA adds NAION eye-risk warning to all GLP-1 labelsNov 9 UTC
euronewseuronews.com · Nov 9, 5:19 PM UTC1
1. US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision lossNov 9 UTC
Medical Malpractice Lawyersmedicalmalpracticelawyers.com · Nov 9, 5:35 PM UTC1
1. FDA Requires Safety Labeling Changes For GLP-1 RAs Due To Potential Increased Risk Of Rare But Serious Eye ConditionNov 9 UTC
CNNcnn.com · Nov 9, 5:50 PM UTC1
1. US FDA orders new eye risk warnings for Ozempic, ZepboundNov 9 UTC
ophthalmologytimes.comNov 9, 5:54 PM UTC1
1. FDA requires NAION warning across the GLP-1 receptor agonist class | Eye Care Network - Ophthalmology TimesNov 9 UTC
NBC Newsnbcnews.com · Nov 9, 6:14 PM UTC1
1. FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindnessNov 9 UTC

Who reported what

Points more than one outlet reported

Points only one outlet reported9

Only reported by Google News Kenya (KE:en)

Only reported by The Independent

Only reported by Google News México (MX:es-419)

Each line is the claim as we recorded it from that outlet's report. Compared as of November 10, 2026 at 12:02 AM UTC.

Who's involved

Who's involved

Organizations

United States Food and Drug Administrationagency of the US Department of Health and Human Services

Places

United States